Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. - Wikidata - awgldk - TriplyDB

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

http://www.wikidata.org/entity/Q39112475

about

Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.Stressed podocytes-mechanical forces, sensors, signaling and response.The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'-implications for pre-clinical research and drug testing.Invited response to "Hyperfiltration After Donation and Living Kidney Donor Risk".A more tubulocentric view of diabetic kidney disease.Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia.Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.Serum creatinine levels and risk of incident type 2 diabetes mellitus or dysglycemia in middle-aged Japanese men: a retrospective cohort study.Role of Kidney Biopsies for Biomarker Discovery in Diabetic Kidney Disease.Haemodynamic or metabolic stimulation tests to reveal the renal functional response: requiem or revival?Chronic kidney disease Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease - Implications for Clinical Practice

P2860

Q38377453-227282B6-4780-4688-B978-21E9CE67C781 Q38661145-C3466742-75A4-436F-808D-5E620825CF17 Q41989543-1E79254A-DE8E-4A31-8992-6CFAC0300F59 Q46430864-76BC56A8-A6A0-4021-9683-08B51A9559E1 Q47108081-C8FE8C57-B476-49F5-901A-248900FF0CAA Q47265349-4D10BB1A-5B72-4FD4-B42F-EEF97B4ADDA6 Q47613477-C2952760-1244-4886-AECA-D8D9E97E1314 Q47915074-3CF627A8-7974-4903-8307-7B4C689A2EB5 Q49960373-59CEBDB6-6470-4E70-BD69-C84BC3B0112F Q51246501-C27C2061-D71B-45D0-87D3-E21B12778AC6 Q52630076-6390E773-55A3-4ACA-B53D-A68E3F539D51 Q57053865-E2605064-938C-49DD-BA35-3847B97297C2 Q57701181-EEDC792E-38AF-4FC5-BABD-5599ED8FD7E9 Q57822732-D9F53CF0-1259-436C-892D-C925F43021D8

P2860

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

http://www.wikidata.org/entity/Q39112475

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@en

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@nl

type

label

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@en

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@nl

prefLabel

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@en

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@nl

P1433

Q39112475-ECD0D101-323C-460D-AEA1-1C386C1634D8

P1476

Q39112475-94203C5D-8879-4F82-8CD6-C2167486E37D

P2093

Q39112475-45EDAC55-0C3D-4EF0-8836-9A71EEBC9E1F

Q39112475-A73FDC14-BECC-415D-A751-042BE4C9C4BC

Q39112475-D7AC1127-A550-49F8-9078-8DBD03DE134D

Q39112475-DF48A21F-F3F7-409D-9B1B-A67C8ECE19A1

Q39112475-EAB21F60-3543-4525-AD5D-628EEB5500BB

P2860

Q39112475-0029E9EC-DBFC-41C8-9B8B-0F3B3D70B92A

Q39112475-01B7AB36-853E-4409-99D2-12603834A271

Q39112475-036C5318-020D-4541-AF61-781B3213CC77

Q39112475-03CE58FC-FA60-474E-8EAD-E5E067BA9C2B

Q39112475-03F53C6A-9273-4D53-8955-2E1F50E414F9

Q39112475-054FC3F5-6413-4DFB-8EBC-80520750E332

Q39112475-08A380B4-1DA9-4E0A-94C9-329042D3A1F8

Q39112475-08B98068-751A-4B39-81D5-1CEE94656920

Q39112475-09CE0CE8-1F4E-45E2-87CF-DA24FC682E82

Q39112475-0AC2DE7F-06F5-4DB9-B26E-47B032E086F1

P304

Q39112475-2F11C789-FEEF-4AD0-BD42-EFF51CAC6114

P31

Q39112475-56A29222-0898-45A0-98B5-C676624D366C

P356

Q39112475-81F0CEA8-3B1A-4993-A92D-0AB58F9F05A9

P433

Q39112475-C2FE9180-4CF1-482C-8404-C1715359DD74

P478

Q39112475-4DDCAE69-C7B7-460A-AC27-7B14708455E1

P50

Q39112475-5AB53F48-5401-4E20-9DE8-1EACAEDF1F7E

Q39112475-C6F55A13-EE4C-4D52-8178-8F10AABB939C

P577

Q39112475-941FDAF6-285E-4EAE-8E84-08F9EA67C18F

P698

Q39112475-46B9F659-3CB6-436A-879D-84E056725C15

P932

Q39112475-715019BB-9A5A-4107-B1C8-8E50CE3EC536

P356

P1433

Journal of the American Society of Nephrology

P1476

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

@en

P2093

Daniël H van Raalte

http://www.w3.org/2001/XMLSchema#string

Erik J van Bommel

http://www.w3.org/2001/XMLSchema#string

Hiddo J L Heerspink

http://www.w3.org/2001/XMLSchema#string

Jaap A Joles

http://www.w3.org/2001/XMLSchema#string

Lennart Tonneijck

http://www.w3.org/2001/XMLSchema#string

P2860

C-Peptide: the missing link in diabetic nephropathy?

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor

Diabetic kidney disease: a report from an ADA Consensus Conference

Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

Hypertrophy and hyperfunction of the diabetic kidney

Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial

P304

1023-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2016060666

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Marcel H.A. Muskiet

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28143897

http://www.w3.org/2001/XMLSchema#string

P932

5373460

http://www.w3.org/2001/XMLSchema#string